Amneal Spreads Bets On Generics Amid Focus On High-Barrier Opportunities
Generics Growth Supports Overall Increase In Q1 As Specialty Segment Falters
• By David Wallace
Amneal is focusing on generics with high barriers to entry • Source: Shutterstock 
